Yeast-model-based study identified myosin- and calcium-dependent calmodulin signalling as a potential target for drug intervention in chorea-acanthocytosis by Soczewka, P. et al.
This is a repository copy of Yeast-model-based study identified myosin- and 
calcium-dependent calmodulin signalling as a potential target for drug intervention in 
chorea-acanthocytosis.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/142460/
Version: Published Version
Article:
Soczewka, P., Kolakowski, D., Smaczynska-de Rooij, I. et al. (4 more authors) (2019) 
Yeast-model-based study identified myosin- and calcium-dependent calmodulin signalling 
as a potential target for drug intervention in chorea-acanthocytosis. Disease Models and 
Mechanisms, 12 (1). dmm036830. ISSN 1754-8403 
https://doi.org/10.1242/dmm.036830
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
RESEARCH ARTICLE
Yeast-model-based study identified myosin- and calcium-
dependent calmodulin signalling as a potential target
for drug intervention in chorea-acanthocytosis
Piotr Soczewka1, Damian Kolakowski1, Iwona Smaczynska-de Rooij2, Weronika Rzepnikowska1,*,
Kathryn R. Ayscough2, Joanna Kaminska1 and Teresa Zoladek1,‡
ABSTRACT
Chorea-acanthocytosis (ChAc) is a rare neurodegenerative disease
associated with mutations in the human VPS13A gene. The
mechanism of ChAc pathogenesis is unclear. A simple yeast model
was used to investigate the function of the single yeast VSP13
orthologue, Vps13. Vps13, like human VPS13A, is involved in
vesicular protein transport, actin cytoskeleton organisation and
phospholipid metabolism. A newly identified phenotype of the
vps13Δ mutant, sodium dodecyl sulphate (SDS) hypersensitivity,
was used to screen a yeast genomic library for multicopy
suppressors. A fragment of the MYO3 gene, encoding Myo3-N (the
N-terminal part of myosin, a protein involved in the actin cytoskeleton
and in endocytosis), was isolated. Myo3-N protein contains a motor
head domain and a linker. The linker contains IQ motifs that mediate
the binding of calmodulin, a negative regulator of myosin function.
Amino acid substitutions that disrupt the interaction of Myo3-N with
calmodulin resulted in the loss of vps13Δ suppression. Production of
Myo3-N downregulated the activity of calcineurin, a protein
phosphatase regulated by calmodulin, and alleviated some defects
in early endocytosis events. Importantly, ethylene glycol tetraacetic
acid (EGTA), which sequesters calcium and thus downregulates
calmodulin and calcineurin, was a potent suppressor of vps13Δ. We
propose that Myo3-N acts by sequestering calmodulin,
downregulating calcineurin and increasing activity of Myo3, which is
involved in endocytosis and, together with Osh2/3 proteins, functions
in endoplasmic reticulum-plasma membrane contact sites. These
results show that defects associated with vps13Δ could be overcome,
and point to a functional connection between Vps13 and calcium
signalling as a possible target for chemical intervention in ChAc.
Yeast ChAc models may uncover the underlying pathological
mechanisms, and may also serve as a platform for drug testing.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Yeast, Chorea-acanthocytosis, Vps13, Myo3,
Calcium signalling, Endocytosis
INTRODUCTION
The VPS13 (vacuolar protein sorting 13) proteins are conserved
among eukaryota. In humans, the VPS13 protein family consists of
four members encoded by the VPS13A, B, C and D genes (Velayos-
Baeza et al., 2004). Mutations in VPS13A lead to a rare, fatal
neurodegenerative disease: chorea-acanthocytosis (ChAc; OMIM
200150) (Rampoldi et al., 2001; Rubio et al., 1997; Ueno et al.,
2001). ChAc is characterised by many neurological symptoms,
including: chorea; dystonia and twitches; and, often, the presence of
acanthocytes (erythrocytes with a spiked morphology) (Hardie et al.,
1991). Several studies have shown a role of the VPS13 proteins in
cytoskeletal organisation (De Franceschi et al., 2011; Föller et al.,
2012), vesicular transport (Honisch et al., 2015; Schmidt et al., 2013),
autophagy (Muñoz-Braceras et al., 2015) and phosphatidylinositol
metabolism (Park et al., 2015); however, the molecular functions
remain unclear. Mutations that cause ChAc usually result in a
reduction or absence of VPS13A, but several cases of patients with
amino acid substitutions have been described (reviewed in
Rzepnikowska et al., 2017b). Mutations in the other VPS13 genes
are also associated with various neurological, mental and
developmental disorders and intellectual disabilities (Fromer et al.,
2014;Kolehmainen et al., 2003; Lesage et al., 2016). Studies have also
reported links between mutations in the VPS13 genes with diabetes
(Grarup et al., 2011; Saxena et al., 2010) and with cancer (Furukawa
et al., 2011; Morisaki et al., 2014). Currently, there is not an effective
therapy for neurodegenerative disorders linked to VPS13 mutations.
There is a single Vps13 protein of 3144 amino acid residues (aa)
in the yeast Saccharomyces cerevisiae. This yeast Vps13 protein
shares the highest degree of similarity (in terms of domain structure)
with human VPS13A. The yeast VPS13 gene was initially identified
in a screen for mutants that secrete the vacuolar enzyme
carboxypeptidase Y (CPY; EC 3.4.16.1), which implies a role in
protein targeting to the vacuole (Bankaitis et al., 1986). Further
studies, including those modelling mutations identified in patients,
showed the importance of Vps13 in vesicular transport, particularly
for Golgi-to-vacuole transport (Brickner and Fuller, 1997; De et al.,
2017; Redding et al., 1996; Rzepnikowska et al., 2017a), endosomal
trafficking (Dalton et al., 2017; Luo and Chang, 1997; Rzepnikowska
et al., 2017a) andmitochondrial DNAmaintenance (Park et al., 2016).
Furthermore, it was recently shown that Vps13 is present atmembrane
contact sites – zones of physical contact between two organelles or
between an organelle and a plasma membrane, which mediate direct
transport of lipids, ions and metabolites. So far, Vps13 has been
identified at the nuclear-vacuolar junction (NVJ), at the endosomal-
mitochondrial junction (EMJ) and at the vacuolar-mitochondrialReceived 10 August 2018; Accepted 7 January 2019
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junction (v-CLAMP) (Lang et al., 2015; Park et al., 2016; reviewed
in Rzepnikowska et al., 2017b). Vps13 is able to bind to
phosphatidylinositol lipids via four different sites: N-terminal;
C-terminal; and internal SHR-BD and APT1 domains (De et al.,
2017; Rzepnikowska et al., 2017a). In addition, the null mutant
exhibits a severe sporulation defect (Brickner and Fuller, 1997) due to
involvement of Vps13 in formation of the prospore membrane
(Nakanishi et al., 2007; Park and Neiman, 2012). Finally, Vps13
interacts with actin and actin cytoskeleton proteins, and has an impact
on the actin cytoskeleton organisation (Michelot et al., 2010;
Rzepnikowska et al., 2017a). Since actin patches are sites of
endocytosis, defects in the functioning of the actin cytoskeleton are
accompanied by a defect in endocytosis in vps13Δ cells (Luo and
Chang, 1997; Rzepnikowska et al., 2017a), as observed in several
other actin cytoskeleton mutants (Huckaba et al., 2004).
Endocytosis is a process that enables the uptake of extracellular
materials and is involved in the regulation of plasma membrane
composition. After initiation of endocytosis, an invagination of the
plasmamembrane is formed, followed by scission and formation of an
endocytic vesicle. The force needed for membrane invagination is
mainly produced during assembly of actin filaments at the endocytic
site. One of the key players during this step is the Arp2/3 complex
(reviewed in Goode et al., 2015). This complex is an actin nucleation
factor and gives rise to branched actin filaments, facilitating a burst of
actin assembly. The action of Arp2/3 is supported by a group of
proteins called nucleation-promoting factors; among them are Las17,
type I myosins and Abp1 (reviewed in Goode et al., 2015). In S.
cerevisiae there are two type I myosins encoded by the homologous
MYO3 andMYO5 genes. A single deletion of eitherMYO3 orMYO5
results in minor defects; however, the double-knockout mutant shows
severe defects in actin polymerisation that result in impaired
endocytosis and growth (Geli and Riezman, 1996; Goodson et al.,
1996). In Myo3/5, several regions can be identified: a motor head
domain; a linker region; and a tail, which promotes actin nucleation
(Anderson et al., 1998). Recruitment of Myo5 to endocytic sites is
regulated by calmodulin, a highly conserved, calcium-binding,
regulatory protein of 147 aa (Grötsch et al., 2010). Calmodulin
binds to IQ motifs found in the linker region of Myo5 (Geli et al.,
1998). Upon binding of calmodulin, Myo5 changes its conformation
from open to closed, in which form it is unable to bind to membranes
and perform its functions (Geli et al., 1998). At endocytic sites, Myo5
facilitates membrane internalisation via both motor and nucleation
functions (Sun et al., 2006). Calmodulin also binds to the Arc35
subunit of the Arp2/3 complex (Schaerer-Brodbeck and Riezman,
2003), and to the Rvs167 endocytic protein involved in vesicle
scission (Myers et al., 2016). Thus, endocytosis and the actin
cytoskeleton organisation are regulated by calmodulin in several ways.
Calcium ions (Ca2+) are one of the most crucial signalling
molecules that enable cells to adapt to changes in internal and
external conditions. Cytosolic Ca2+ concentration is maintained at
low levels, 50-200 nM (Iida et al., 1990; Nakajima-Shimada et al.,
1991), and is regulated by a system of calcium pumps present in the
membranes. In yeast, Ca2+ is stored mainly in vacuoles (Dunn et al.,
1994), but also in the Golgi apparatus and endoplasmic reticulum
(ER) (Pezzati et al., 1997). Changes in cytosolic Ca2+ concentration
influences the state of calmodulin, which can be present in Ca2+-free
or Ca2+-bound forms. The different forms have different protein targets
(reviewed in Cyert, 2001; Yap et al., 1999). One of the Ca2
+-independent targets is Myo5. Among Ca2+-dependent targets, there
is a protein phosphatase calcineurin (reviewed in Cyert, 2001) and
Arc35 (Schaerer-Brodbeck and Riezman, 2003). Calcineurin is a
heterodimer consisting of catalytic and calmodulin-binding subunit
A – which, in S. cerevisiae, is encoded by two redundant genes,
CNA1 and CMP2 (CNA2) – and a regulatory and calcium-binding
subunit B, encoded by the CNB1 gene (Cyert et al., 1991; Cyert and
Thorner, 1992; Liu et al., 1991). Upon activation by calmodulin,
calcineurin mediates the response to changes in Ca2+ concentration
through its main target, Crz1 (Matheos et al., 1997; Stathopoulos
and Cyert, 1997). Crz1 is a transcription factor, which, after
dephosphorylation by calcineurin, translocates to the nucleus and
binds to calcineurin-dependent response elements (CDREs),
enabling calcineurin-driven gene expression (Stathopoulos-
Gerontides et al., 1999; Stathopoulos and Cyert, 1997).
Calmodulin and calcineurin are highly conserved in eukaryotes,
are crucial for calcium signalling (reviewed in Cyert, 2001), and are
essential for the function and development of the central nervous
system. Expression of calcineurin catalytic subunits in the brain is
significantly higher than in other organs (Bond et al., 2017) and
mutations in these subunits or changes in activity, both down- and
upregulation, result in neurological disorders (reviewed in
Kipanyula et al., 2016; Mizuguchi et al., 2018). It was also
reported recently that calcium signalling is defective in cells isolated
from ChAc patients (Pelzl et al., 2017a,b). Thus, components of the
calcium signalling pathway are potential targets in therapy for
neurodegenerative diseases.
Studies of yeast vps13mutant, a model for ChAc and other diseases
connected with VPS13 genes, are ongoing. Recently, missense
mutations identified in ChAc patients were modelled in yeast, giving
insight into possible mechanisms of pathogenesis (Park et al., 2016;
Rzepnikowska et al., 2017a). Here, we describe a new growth
phenotype of vps13 mutants, which we found suitable for genetic
screens and drug testing. Our genomic library screen revealed aMYO3
gene fragment as amulticopy suppressorof vps13-I2749R and vps13Δ
phenotypes, proving that both point mutations in, and deletions of,
VPS13 could be overcome. Further genetic and biochemical analyses
pointed to calcium signalling,with the involvement of calmodulin and
calcineurin, as an important factor for the alleviation of vps13 defects.
Our new phenotype could be useful for drug screening, as
demonstrated by testing with calcineurin inhibitors. These findings
can help to better understand themechanisms ofChAc andwill help to
develop new treatments in the future.
RESULTS
Inactivation of VPS13 causes hypersensitivity to sodium
dodecyl sulphate in yeast cells
In our previous study we discovered that vps13 mutant cells, either
vps13Δ or vps13-I2749R, with a single amino acid substitution in
the APT1 domain of Vps13 corresponding to the I2771R mutation
found in a ChAc patient, exhibit defects in actin cytoskeletal
organisation and endocytosis (Rzepnikowska et al., 2017a). Various
mutants that exhibit defects in the actin cytoskeleton, in protein
transport, in cell wall integrity or have altered calcium homeostasis
are hypersensitive to low concentrations of sodium dodecyl sulphate
(SDS) (Ammons et al., 2015; Chen et al., 2012; Fokina et al., 2012;
Varelas et al., 2006), a small amphiphilic detergent. Therefore, we
tested both vps13Δ and vps13-I2749R mutants for growth in the
presence of this compound. Both vps13 mutants appeared
hypersensitive to the addition of 0.03% SDS to the rich medium
(Fig. 1A), and vps13Δwas most sensitive. In addition, we found that
other mutants that are defective in actin cytoskeleton organisation
and endocytosis (end3Δ, sla2Δ, ede1Δ, sla1Δ and rvs167Δ), or
defective in Golgi transport or endocytic sorting (cog5Δ, cog8Δ,
vps15Δ, vps35Δ, vps27Δ, stp22Δ, vps36Δ and vps24Δ), are also
hypersensitive to low concentrations of SDS (Fig. 1B,C). Under
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SDS stress conditions, Golgi and endocytic traffic are probably
crucial for the effective replacement of plasma membrane proteins
that have been damaged by SDS.
It was previously documented that SDS damages the cell wall and
plasma membrane in Pichia pastoris yeast cells (reviewed in Levin,
2005; Zhang et al., 2015); therefore, we investigated whether the
cell wall integrity is compromised in vps13Δ. Cellular integrity in
yeast is mainly controlled by the cell wall integrity (CWI) pathway
(reviewed in Levin, 2005), which employs one branch of a mitogen-
activated protein kinase (MAPK) cascade for signal transduction.
This MAPK signalling pathway involves protein kinase C, Bck1,
Mkk1/2 and Slt2/Mpk1 kinase, which further phosphorylates and
activates transcription factors to produce proteins involved in cell
wall biogenesis and other processes. Increased phosphorylation of
Slt2 usually indicates a defect in cell wall integrity. Investigation of
the level of phosphorylated Slt2 by western blotting using anti-
phospho-p44/42 MAPK antibody in vps13Δ cell extracts revealed
that levels were similar to the wild type. This finding supports the
view that the CWI pathway is not activated and cell wall integrity is
not compromised in vps13Δ cells grown in regular growth medium
(Fig. 1D). Addition of SDS to the medium activated the CWI
pathway in vps13Δ cells with approximately 5-fold higher
phosphorylation of Slt2 kinase compared to wild type (Fig. 1D).
This activation is apparently not sufficient to compensate for the
damage, caused by SDS, to vps13Δ mutant cells.
A fragment of the MYO3 gene suppresses the SDS
hypersensitivity of vps13-I2749R and vps13Δ cells
To determine whether vps13 mutations can be overcome, and to
elucidate the importance of Vps13-dependent processes in SDS
tolerance, we performed a screen for multicopy suppressors of
vps13-I2749R. The vps13Δ strain carrying the vps13-I2749R allele
Fig. 1. The vps13mutants are hypersensitive to SDS but cell wall integrity is not compromised. (A) vps13mutants are hypersensitive to SDS. (B) Mutants
defective in endocytosis are hypersensitive to SDS. (C) Mutants defective in Golgi transport or endocytic sorting are hypersensitive to SDS. (D) Slt2 is
hyperphosphorylated in vps13 cells following SDS stress. Overnight yeast cultures were shifted to fresh YPD or YPD+0.03% SDS and incubated for 3 h. Western
blot was performed and analysed by densitometry. The phosphorylation levels of Slt2 in relation to Pgk1 were compared by one-way ANOVA followed by Tukey’s
multiple comparison test (n=3); **P<0.01. Error bars indicate s.d.
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on a plasmid was transformed with a multicopy genomic library.
Several clones, bearing various none-overlapping genomic
fragments, were able to grow on SDS-containing medium, and
plasmids from these clones were isolated, retested for suppression
and sequenced. One plasmid contained a fragment of the MYO3
gene (MYO3-N) encoding the N-terminal 1-775 aa of type I myosin
(Myo3-N), an actin cytoskeleton protein involved in endocytosis
(Geli and Riezman, 1996; Goodson and Spudich, 1995), which was
responsible for suppression. The Myo3-N fragment consists of: a
motor domain (aa 36-715); a linker (aa 719-771), containing two IQ
motifs, indicating ability to bind calmodulin (Ho et al., 2002); and
five amino acids of a tail lipid-binding TH1 domain (aa 771-775)
(Fig. 2A). Subsequently, we found that the MYO3-N fragment also
suppresses the vps13Δ deletion mutation (Fig. 2B). This suggests
that the Myo3-N protein does not suppress defects by directly
interacting with Vps13-I2479R, but instead may involve another
factor. Furthermore, we showed that a fragment of Myo3-N
containing the IQ motifs (aa 680-775) was necessary for
suppression (Fig. 2B), suggesting that calmodulin could be this
other factor.
To verify the hypothesis that calmodulin binding by Myo3-N is
required for suppression, threemyo3-N alleles with one (myo3-iq1,
myo3-iq2) or both (myo3-iq1/2) IQ motifs disrupted were
generated by in vitro mutagenesis (Fig. 2A). To test the
interaction of Myo3-N and Myo3-iq1/2 with calmodulin, we
used a two-hybrid system, which was previously shown to be
appropriate for the detection of the interaction between Myo5 (a
homologue of Myo3) and calmodulin (Geli et al., 1998). As
predicted, Myo3-N interacted with calmodulin but Myo3-iq1/2
protein did not (Fig. 2C). Most importantly, the myo3-iq1/2 allele
was not able to suppress the SDS-hypersensitivity phenotype of
vps13Δ (Fig. 2D), although it was similarly expressed asMYO3-N,
Fig. 2. The MYO3-N fragment encoding the motor domain and calmodulin-binding motifs from Myo3 suppresses hypersensitivity of vps13Δ
to SDS. (A) Schematic representation of Myo3 domain structure and Myo3 variants studied. Myo3 domains and motifs are based on the Uniprot database
(http://www.uniprot.org/uniprot/P36006, 02.08.2018). *, position of mutations introduced in vitro. Amino acids conforming to the consensus of the calmodulin-
binding motif as defined in the SMART database (http://smart.embl-heidelberg.de, 02.08.2018). IQ motifs are underlined and amino acid substitutions are
shown. (B) MYO3-N suppresses vps13Δ but MYO3-NΔ680-775 does not. (C) Myo3-N interacts with calmodulin in the two-hybrid system and mutations
in IQ motifs abolish this interaction. BD, DNA-binding domian; AD, activating domain. (D) IQ motifs of Myo3 are required for suppression of vps13Δ.
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when the cellular levels of hemagglutinin (HA)-tagged versions of
protein products were compared (Fig. S1). The myo3-iq1 and
myo3-iq2 mutant alleles, each with a single IQ motif removed,
were less efficient in suppression than MYO3-N (Fig. 2D). The
additive effects of IQ deletions were previously observed for
MYO5 (Geli et al., 1998). Our results indicate that the mechanism
by whichMYO3-N suppresses vps13Δ requires binding of Myo3-N
to calmodulin and that calmodulin signalling affects the vps13Δ
phenotype.
Crz1-dependent transcriptional response is increased in
vps13Δ
Calmodulin has several targets in yeast, including the protein
phosphatase calcineurin, which is important in the response of cells
to stress (reviewed in Cyert, 2001). In response to increased
cytoplasmic calcium upon stress, calmodulin binds and activates
calcineurin, which subsequently dephosphorylates and activates the
transcription factor Crz1 (Matheos et al., 1997; Stathopoulos and
Cyert, 1997) to promote cell survival. To compare activity of
calcineurin in wild-type and vps13Δ cells, and in these cells upon
expression ofMYO3-N, we used a plasmid containing a calcineurin-
dependent response elements (CDREs) fused to the lacZ open
reading frame encoding β-galactosidase (Stathopoulos and Cyert,
1997) (Fig. 3A). Activity of β-galactosidase was measured in cell
extracts derived from respective transformants. Results show that
the activity of calcineurin is significantly increased in vps13Δ when
compared to the wild-type strain (Fig. 3B) and it is reduced by the
expression of MYO3-N (Fig. 3B). These results imply that
cytoplasmic calcium concentration could be increased in vps13Δ
and thatMyo3-Nmight act by binding and sequestering calmodulin,
which in turn causes deactivation of calcineurin. This suggests that
deactivation of calcineurin by genetic manipulation or by chemical
inhibitors might possibly cause suppression.
PMC1 gene, encoding vacuolar calcium pump, is amulticopy
suppressor of vps13Δ
To address the question of whether an increased cytoplasmic
calcium level is the reason for hyperactivation of calcineurin in
vps13Δ, we tested the effect of overexpression of PMR1 and PMC1
genes for growth of vps13Δ on SDS medium. These genes encode
ER/Golgi or vacuolar calcium pumps, respectively, and transport
calcium out of the cytoplasm. We found that PMC1, but not PMR1,
is a potent suppressor (Fig. 3C). We analysed further whether the
defect of vacuolar transport of calcium in pmc1Δ is alone sufficient
to decrease yeast cell tolerance to SDS and found that pmc1Δ is
hypersensitive to SDS but less than vps13Δ (Fig. 3C). Since
vps13Δ shows defects in Golgi-to-vacuole transport, the pathway
needed for normal Pmc1 targeting, the Pmc1 pump could possibly
be mislocalised in these cells. Thus, mislocalisation of Pmc1 could
be one of the reasons for vps13Δ hypersensitivity to SDS.
However, we were unable to prove this since we could not get
PMC1-mCherry vps13Δ clones. This suggests that such cells
might be unviable.
The fine-tuned activity of calcineurin is important for vps13Δ
growth on SDS-containing medium
The Cnb1 regulatory subunit of calcineurin is required for its
activity (Cyert and Thorner, 1992). It has been reported that the
cnb1Δ strain is more sensitive to a variety of stresses (Mulet et al.,
2006), but there is no data relating to the sensitivity to SDS.
Therefore, to analyse how calcineurin deactivation affects the
Fig. 3. Activity of calcineurin is increased in vps13Δ and reduced by
MYO3-N, and PMC1 suppresses the vps13Δ growth defect. (A) Schematic
representation of the calcineurin-Crz1 signalling system used to measure the
activity of calcineurin. (B) Activity of calcineurin is increased in vps13Δ and
is diminished by MYO3-N. Results were analysed statistically by one-way
ANOVA followed by Tukey’s multiple-comparisons test (n=6 for WT [-] and
vps13 [-], n=3 for WT [MYO3-N] and vps13Δ [MYO3-N]; **P<0.01, ***P<0.001).
Error bars indicate s.d. (C) PMC1 is a multicopy suppressor of vps13Δ
hypersensitivity to SDS and pmc1Δ is hypersensitive to SDS. Growth of wild-
type and vps13Δ transformed with plasmids bearing PMR1 or PMC1, or with
empty vector (left panel). Growth of wild-type, vps13Δ and pmc1Δ strains on
SDS medium (right panel).
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response to SDS in vps13Δ cells and to establish whether active
calcineurin is required for vps13Δ suppression by MYO3-N, the
growth of wild-type, cnb1Δ and cnb1Δ vps13Δ mutants on SDS-
containing medium was compared in the presence or absence of
MYO3-N. We found that the cnb1Δ strain is more sensitive to SDS
than the wild-type strain and that cnb1Δ mutation negatively
interacts genetically with vps13Δ (Fig. 4A), indicating that vps13Δ
cells rely on active calcineurin to cope with SDS stress.
Interestingly, the cnb1Δ vps13Δ mutant was not suppressed by
MYO3-N, indicating that Myo3-N requires the Cnb1 protein and
functional calcineurin for vps13Δ suppression (Fig. 4A). Thus, it
seems that a certain level of calcineurin activity is required for
normal growth in the presence of SDS. Sequestration of calmodulin,
the activator of calcineurin, by MYO3-N results in a reduction in
calcineurin activity, thus fine tuning calcineurin activity to this
required level.
The contribution of Crz1 to the SDS stress response and to the
MYO3-N suppression of vps13Δ was also studied. Comparison of
the growth of isogenic crz1Δ and crz1Δ vps13Δ mutants with
vps13Δ and with the wild-type strain revealed that the crz1Δ strain
exhibits a similar sensitivity to SDS as the wild-type strain in
conditions tested. It also revealed that crz1Δ vps13Δ grows more
slowly than vps13Δ but suppression by MYO3-N is still observed
(Fig. 4A). These results show that the Crz1 transcription factor
positively contributes to SDS stress tolerance in vps13Δ and, most
importantly, that vps13Δ suppression by MYO3-N involves a
mechanism that is independent of Crz1 activity.
To investigate the possibility of using chemical intervention in
the vps13Δ strain, we tested the effects of: ethylene glycol tetraacetic
acid (EGTA), a chelator of divalent cations that is more specific for
Ca2+ than for other cations; and FK506, a calcineurin inhibitor.
EGTA reduces the concentration of calcium in the cytoplasm, thus
Fig. 4. A normal/intermediate activity of calmodulin-calcineurin pathway is required to cope with SDS stress in vps13Δ. (A) Growth of wild-type, vps13Δ,
cnb1Δ, crz1Δ, vps13Δ cnb1Δ and vps13Δ crz1Δ cells expressing, or not, MYO3-N on YPD+SDS. (B) Addition of EGTA improves growth of vps13Δ on SDS-
containing medium. (C) FK506 affects growth of vps13Δ on SDS-containing medium. Strains were grown to early exponential phase. Cells (0.05 OD) were plated
on YPD+0.035% SDS, and 2 µl of 0-10 µM FK506 (HY-13756, MedChemExpress, Monmouth Junction, USA) was applied on paper discs as indicated.
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inhibiting the Ca2+-dependent action of calmodulin and inhibiting
calcineurin. Interestingly, addition of EGTA significantly improved
growth of vps13Δ on SDS plates (Fig. 4B). Thus, a partial inhibition
of the calcium-dependent functions of calmodulin and the inhibition
of calcineurin is beneficial for vps13Δ cells in the presence of SDS
stress. FK506 improved growth of vps13Δ at low concentrations
(2.5 μM spotted onto filter paper), but higher concentrations
exhibited an adverse effect (Fig. 4C). Thus, calcineurin cannot be
inhibited completely, but its downregulation can be fine-tuned in
order to improve the growth of vps13 cells. This result points to
FK506 as a potential drug and to calcineurin as a useful target to
select drugs for ChAc therapy.
The cmd1-226mutant allele, encoding a calmodulin variant
with the F92A amino acid substitution, suppresses vps13Δ
The importance of calmodulin binding by Myo3-N for the
suppression of vps13 suggests that a calmodulin sequestration
mechanism is involved. To verify this assumption, we analysed
whether expression of multiple copies of CMD1 alleles encoding
wild-type or mutant calmodulin have an effect on the growth of
vps13Δ cells in the presence of SDS. The various cmd1 alleles were
selected to represent different groups of mutants with the same
phenotype: defective actin cytoskeleton, altered localisation of
calmodulin, defective karyokinetic spindle or defective budding, as
previously described (Geli et al., 1998; Ohya and Botstein, 1994).
The wild-type CMD1 negatively affected growth of vps13Δ cells,
implying that the control of the calmodulin pool and/or accessibility
to different substrates is important for regulation of the cell response
to SDS stress in vps13Δ, supporting the sequestration mechanism
forMYO3-N (Fig. 5A). The cmd1-231 allele, which causes a defect
in budding, affected growth similarly to wild-type CMD1, while the
mutant cmd1-228 and cmd1-239 alleles essentially did not affect
growth of vps13Δ. Surprisingly, the cmd1-226 allele, which results
in the F92A substitution in calmodulin and represents a group of
mutants that show defects in the organisation of the actin
cytoskeleton and in endocytosis, was a potent suppressor of
vps13Δ (Fig. 5A).
To test how overproduction of wild-type or mutant calmodulin
affects activity of calcineurin in vps13Δ cells, the CDRE-lacZ
reporter was used. Interestingly, neither wild-type nor mutant
calmodulin genes, including the cmd1-226 suppressor allele,
significantly affected the increased activity of calcineurin in
vps13Δ cells (Fig. 5B). Since additional calmodulin did not have
an effect in vps13Δ, we checked whether calcineurin could be
stimulated by addition of calcium to the medium in this strain. Wild-
type and vps13Δ cells showed higher activity of calcineurin after
calcium addition, indicating that calcineurin activity in vps13Δ in
regular conditions is not maximal (Fig. 5C). Moreover, in wild-type
cells, the effect of calcium and expression of additional copies of
CMD1was additive. However, vps13Δ cells expressingCMD1 from
the plasmid did not significantly increase calcineurin activity in the
presence or absence of additional calcium. Thus, even when
calcium is not a limiting factor, further activation of calcineurin by
Cmd1 requires Vps13. These results indicate that reduction of
calcineurin activity is probably not a mechanism for restoring
growth of vps13 cells on SDS plates mediated by cmd1-226. The
Cmd1-226 mutant protein might target proteins other than
calcineurin. One possibility is that Cmd1-226 is different in terms
of its binding with Myo3, as is the case for Myo2 (Sekiya-Kawasaki
et al., 1998). Therefore, we analysed how selected cmd1 mutations
affect the interaction of calmodulin with Myo3 using a two-hybrid
system. This analysis shows that the cmd1-226mutation, in contrast
to other mutations tested, results in total loss of interaction between
calmodulin and Myo3-N (Fig. 5D). Thus, a complete loss of
interaction between mutant calmodulin and Myo3 is required for
cmd1-226-based suppression, the opposite to MYO3-N-based
suppression of vps13Δ. Cmd1-226 may act by diluting wild-type
calmodulin and activating full-length Myo3, or by other
mechanisms.
Expression of MYO3-N suppresses the actin cytoskeleton
polarisation and endocytosis defects of vps13Δ
We have previously reported that vps13Δ shows defects in the
organisation of the actin cytoskeleton that are accompanied by an
endocytosis defect, observed as canavanine hypersensitivity
(Rzepnikowska et al., 2017a). We found that MYO3-N suppresses
the actin cytoskeleton polarisation defect of vps13Δ, since a greater
number of cells with properly polarised actin patches in the bud,
visible actin cables in the mother, and without actin clumps, were
found when MYO3-N was expressed (Fig. 6A). The vps13Δ cells
expressing MYO3-N were less sensitive to canavanine than vps13Δ
cells bearing empty vector (Fig. 6B), also indicating that
endocytosis is improved.
Actin patches are sites where endocytosis takes place (Huckaba
et al., 2004). Vps13 has been found in artificial actin patches
assembled on microbeads covered with the nucleation-promoting
factor Las17 (yeast WASP) (Michelot et al., 2010). Therefore, it is
possible that Vps13 is directly involved in the early steps of
endocytosis and/or that the early steps of endocytosis in vps13Δ cells
are disturbed by the actin cytoskeleton malfunctioning. To test this
possibility, the lifetimes of endocytic reporters fused with a
particular fluorescent protein (GFP or mCherry) in cortical patches
were determined in the wild-type and vps13Δ strains. Kymographs,
indicating the behaviour of individual patches, were also obtained.
The reporter proteins analysed represent actin cytoskeleton
components that associate temporarily with the endocytic vesicle
as it forms. They are thus used for the visualisation of specific stages
of endocytosis. Myo3/5 work together with Las17 in the myosin/
WASPmodule to activate actin polymerisation (reviewed inLu et al.,
2016). Abp1 acts later in the actin module and is a marker that tracks
invagination of the plasma membrane and inward endocytic vesicle
movement. The actin cytoskeleton regulators Las17, Myo3, Myo5
and Abp1 were monitored by fluorescence microscopy. In vps13Δ
cells, the lifetimes of the patches formed by all of these proteins were
longer than in respective control cells, 32.32 for Las17-GFP, 13.66
forMyo3-GFP, 13.55 forMyo5-GFPand 20.37 s forAbp1-mCherry
as opposed to 26.38, 11.29, 11.49 and 17.01 s, respectively
(Fig. 7A). Lifetimes of Las17-GFP and Myo5-GFP were partially,
but significantly, shortened whenMYO3-Nwas expressed in vps13Δ
(28.05 and 12.32 s, respectively) (Fig. 7A). MYO3-N did not affect
the lifetime of Abp1-mCherry (19.7 s) (Fig. 7A). Interestingly, the
lifetime of Myo3-GFP patches in vps13Δ cells expressingMYO3-N
was shortened to a normal value (11.14 s) and was statistically not
different from the control strain (Fig. 7A).
Kymographs suggested that the immobile phase of Las17-,
Myo3-, Myo5- and Abp1-associated patches was affected – these
proteins were retained for longer at the plasma membrane in vps13Δ
than in the wild-type cells (Fig. 7B). What is more, the Apb1m-
Cherry patch tracks indicate that the movement of some of the
patches was affected in vps13Δmutant cells (Fig. 7C). At least three
abnormal behaviours of the patches were observed: the patch
remained near the plasma membrane and did not move toward
the centre of the cell (no movement); it moved inward but then
retracted; or it moved in a direction other than towards the cell centre
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(chaotic movement). MYO3-N expression did not influence the
defective patch movement of vps13Δ (Fig. 7C).
In summary, the results suggest that Vps13 is involved in the
early steps of endocytosis and it affects the duration of association of
several actin cytoskeleton proteins with endocytic sites. It also
affects the movement of endocytic vesicles, as observed by Abp1-
mCherry, in terms of occurrence, distance travelled and direction.
Production of Myo3-N in vps13Δ improves endocytosis by
correcting a number of steps in the process, in particular restoring
the functioning of full-length Myo3.
Osh2 and Osh3 proteins bridging cortical ER with plasma
membrane at endocytic sites are essential for suppression
of vps13Δ by MYO3-N
We found that the defects of vps13Δ cells – in endocytosis, in the
extended lifetime of Las17-GFP and in abnormal Abp1 patch
Fig. 5. The cmd1-226 mutant allele, but not wild-type CMD1, restores growth of vps13Δ on YPD+SDS plates. (A) Different CMD1 alleles variously
affect the growth of vps13Δ. (B) Wild-type and mutant calmodulin do not influence calcineurin activity in vps13Δ cells. Results were analysed by one-way
ANOVA (n=3); P=0.196. Error bars indicate s.d. (C) Effects of calcium addition and CMD1 overexpression on calcineurin activity in wild-type and vps13Δ cells.
Results were analysed statistically by two-tailed Student’s t-test (n=6; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Error bars indicate s.d. (D) Cmd1-226
does not interact with Myo3-N. Results from a two-hybrid experiment are shown. BD, DNA-binding domain; AD, activating domain.
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behaviour – are similar to the defects observed in osh2Δ osh3Δ cells
(Encinar del Dedo et al., 2017). Osh2 and Osh3 are components of
ER-plasma membrane contact sites important for endocytosis
(Encinar del Dedo et al., 2017). Therefore, we tested osh2Δ
osh3Δ and other mutants defective in various membrane contact
sites for growth in the presence of SDS and whether Osh2/3 proteins
are required forMYO3-N suppression of vps13Δ. The nvj1Δ, vps39Δ
andmmm1Δmutants, lacking the proteins involved in the formation
of nuclear-vacuolar junctions, v-CLAMPs and ER-mitochondria
encounter structures (ERMES), respectively, grew as wild type on
SDS-containing medium, showing that these membrane contact
sites are not important in this condition (Fig. S2). The analysis of
osh2Δ osh3Δ double mutants, and osh2Δ osh3Δ vps13Δ triple
mutants, transformed with MYO3-N plasmid or empty vector,
revealed that: the osh2Δ osh3Δ strain is much more sensitive to SDS
than vps13Δ; the osh2Δ osh3Δ vps13Δ is similarly sensitive to
osh2Δ osh3Δ; and neither is suppressed by MYO3-N (Fig. 8).
Therefore, Osh2/3 are crucial for SDS tolerance and, under this
stress condition, act with Vps13 in the same pathway. Finally, Osh2/3
are important for Myo3-N to act as a suppressor of vps13Δ. Thus,
calmodulin-binding motifs of Myo3-N and the presence of full-
length myosin type I linked with Osh2/3 at ER-plasma membrane
endocytic contact sites, but not other membrane contact sites, are
important for growth of the vps13Δ strain on SDS-containing
medium.
DISCUSSION
Vps13 proteins are important for neuronal cell physiology, as
mutations in VPS13 genes cause genetic neurodegenerative
disorders in humans. Despite this importance, the molecular
function of Vps13 and pathogenesis of associated diseases are
still unclear. Using a yeast model for ChAc, a vps13Δmutant and its
newly discovered SDS-hypersensitivity phenotype, we have
screened for genetic suppressors to see whether the Vps13
deficiency can be overcome and to learn more about the
pathological cellular processes that could be the basis for the
disease. Here, we show that vps13Δ defects can be suppressed by:
MYO3-N, which encodes the Myo3-N myosin fragment that binds
and sequesters calmodulin; expression of the cmd1-226 allele
encoding a mutant calmodulin that is unable to bind myosin; or by
PMC1, encoding a vacuolar calcium pump. We also show that
calcium signalling is activated in vps13Δ and that Myo3-N
downregulates calcineurin activity and acts as a suppressor via a
Crz1-independent mechanism. Furthermore, we show that vps13Δ
can also be suppressed using chemical compounds, EGTA and
FK506, which affect calcium signalling and inhibit calcineurin. Our
studies of early endocytosis events in vps13Δ and genetic analysis
point to the possibility that Vps13 is a component of ER–plasma-
membrane contact sites.
Discovering a new phenotype of vps13Δ cells, hypersensitivity to
SDS, allowed us to perform a successful screen for multicopy
suppressors, but also has potential implications for ChAc patients.
SDS is one of the most popular detergents worldwide. It is used as
an additive to a wide range of cosmetics, pharmaceuticals, and
household and industrial cleaning products. This amphiphilic
compound easily accumulates in living organisms (reviewed in
Cserháti et al., 2002), inhibits growth of bacteria, algae, fishes and
yeasts (reviewed in Lechuga et al., 2016; Sandbacka et al., 2000),
and negatively affects mammalian cells. The hypersensitivity of
vps13Δ to SDS and the abundance of SDS in many everyday
products suggest that ChAc patients may be more vulnerable to a
danger posed by SDS. It could be one of the environmental factors
that influence the time of onset and progression of the disease.
However, sensitivity of human cells to SDS requires further study.
We used vps13Δ yeast as a ChAc model to better understand its
pathophysiology. Our results show that the CWI signalling pathway
was not activated in vps13Δ cells, suggesting that there is no defect
in the cell wall in these cells. Rather, plasmamembrane composition
might be altered due to defects in endocytosis or plasma membrane
stiffness/rigidity affected due to the defect in actin cytoskeleton
organisation in vps13Δ. This may be the reason for low tolerance to
SDS, as supported by the finding that several endocytic mutants
with defects in the actin cytoskeleton and in endocytosis, and
mutants defective in Golgi and endosomal sorting, were also found
to be hypersensitive to SDS. We have found that the CWI pathway
responds to SDS with a much greater level of phosphorylation in
vps13Δ, when compared to wild-type cells, to compensate for
damage caused by the detergent.
Fig. 6. MYO3-N suppresses the actin-
cytoskeleton polarisation defect and the
canavanine hypersensitivity of vps13
cells. (A) MYO3-N suppresses the actin-
cytoskeleton polarisation defect of vps13Δ.
Quantification of actin polarisation was
analysed using the two-tailed Student’s t-test
(n=3; cells counted per replicate: 105; 184;
148 for WT [-], 130; 103; 195 for vps13Δ [-],
138; 111; 121 for vps13Δ [MYO3-N]);
*P<0.05, ***P<0.001. Error bars indicate s.d.
(B) MYO3-N suppresses canavanine
hypersensitivity of vps13Δ.
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Fig. 7. The vps13Δ mutation impairs plasma membrane events involved in endocytosis and MYO3-N suppresses some of the defects. (A) Lifetimes
of Las17-GFP, Myo3-GFP, Myo5-GFP and Abp1-mCherry patches. Results were compared using one-way ANOVA followed by Tukey’s multiple-comparisons
test (n=87; 63; 103; 97 for Las17-GFP, n=163; 212; 207; 192 for Myo3-GFP, n=302; 264; 296; 251 for Myo5-GFP, n=83; 75; 104; 100 for Abp1-mCherry for
WT [-], vps13 [-], WT [MYO3-N] and vps13 [MYO3-N], respectively); *P<0.05, ****P<0.0001. Error bars indicate s.d. (B) Kymographs of Las17-GFP, Myo3-GFP
and Myo5-GFP patches. Two representative kymographs for each strain, as in A, are shown. Las17-GFP patches were observed for 120 s using an
Olympus IX-81 microscope and imaging was performed via 1 s time lapse. Myo3-GFP and Myo5-GFP were observed for 90 s using an OMX DeltaVision V4
microscope and imaging was performed via 0.5 s time lapse. (C) Kymographs of Abp1-mCherry patches. Two representative kymographs for each class of patch
behaviour are shown. Abp1-mCherry patches were viewed for 90 s using an Olympus IX-81 microscope and imaging was performed via 1 s time lapse.
Quantification of the patches was analysed using a two-tailed Student’s t-test (n=5, patches counted per replicate: 44; 45; 54; 55; 65 for WT [-], 50; 47; 60;
47; 60 for vps13Δ [-], 51; 57; 64; 37; 61 for WT [MYO3-N], 54; 69; 59; 67; 59 for vps13Δ [MYO3-N]); ***P<0.001. Statistical significances and error bars
indicating s.d. are shown for patches with normal behaviour.
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Changes in calcineurin activity are connected with several
diseases, including neurodegeneration. Calcineurin signalling was
elevated in vps13Δ, and this is detrimental, as shown for yeast
models for other neurodegenerative diseases (Caraveo et al., 2014).
One possible explanation is that a lack of Vps13 protein causes a
defect in protein trafficking that triggers a cellular response
involving calcineurin upregulation. Our data of vps13Δ
suppression by PMC1 suggest that Pmc1 could be mislocalised in
vps13Δ and inefficient in pumping calcium to the vacuole, resulting
in cytoplasmic calcium increase and calcineurin activation. Such a
view is also supported by negative genetic interaction of vps13Δ
with pmr1Δ (Costanzo et al., 2010). It is also possible that Vps13 is
more directly involved in calcium signalling, since, in high-
throughput studies, Vps13 has been shown to bind calmodulin (Ho
et al., 2002). However, we were not able to confirm this interaction
by other methods. Although detrimental in excess, the activities of
calcineurin and of its Crz1 effector are important for the growth of
vps13Δ cells under SDS stress, similarly to as observed for Candida
glabrata yeast (Chen et al., 2012). Calcium signalling and
calcineurin activity could be upregulated in vps13 cells by at least
two mechanisms: through secondary effects of disrupted transport
processes or through the removal of potential direct interactions.
We have shown that the effects of the vps13Δ mutation,
monitored through growth on SDS medium, can be overcome in
several ways: titration of calmodulin by Myo3-N; expression of
additional copies of PMC1; additional production of mutant
calmodulin Cmd1-226; or addition of calcineurin inhibitors.
Expressed Myo3-N binds to and sequesters free calmodulin,
which activates Myo3/5 and downregulates the activity of
calcineurin. The growth defect of the cnb1Δ vps13Δ mutant is not
suppressed by MYO3-N; however, the crz1Δ vps13Δ mutant was
still suppressed. This suggests that active calcineurin, but not Crz1,
is required for the suppression and only partial downregulation is
beneficial. This effect could be also achieved by lowering
cytoplasmic calcium via overproduction of the Pmc1 vacuolar
calcium pump. This notion is further supported by the finding that
chemical calcineurin inhibitors, EGTA and FK506, suppressed the
vps13Δ growth defect. FK506 suppressed vps13Δ only at a very low
concentration, while at higher concentrations FK506 enhanced the
vps13Δ hypersensitivity to SDS. Our results are in line with
observations that the moderate calcineurin activity is protective for
cells, but elevated or inhibited activity is toxic (Caraveo et al., 2014,
reviewed in Kipanyula et al., 2016). In agreement with a
calmodulin-sequestering model, overproduction of wild-type
calmodulin is harmful to vps13Δ cells in spite of it not affecting
calcineurin activity in vps13Δ cells. The cmd1-226 also did not alter
the calcineurin activity, which suggests that the mechanism of the
suppression in this case is calcineurin independent. One possibility
is that Cmd1-226 dilutes or somehow negatively affects wild-type
calmodulin, what in turn increases the pool of the active forms of
Myo3/5, which contributes to suppression by enhancing
endocytosis. The other possible explanation of cmd1-226 action is
by interacting with Arc35, a subunit of the Arp2/3 complex that
activates the polymerisation of actin filaments. Calmodulin encoded by
cmd1-226 binds to Arc35 protein, while that encoded by cmd1-231,
which was the most toxic to vps13Δ, does not (Schaerer-Brodbeck and
Riezman, 2003). We cannot exclude the possibility that SDS stress
somehow causes cell division defects in vps13Δ andCmd1-226 helps to
overcome this defect by acting on other targets, such as Spc110, a
spindle-pole-body calmodulin-binding protein (Geiser et al., 1993).
As we have documented here, vps13Δ exhibits defects in an early
endocytic processes. These defects include an extended lifetime of
several endocytic actin-cytoskeleton proteins and abnormal Abp1
patch behaviour, which is a marker of endocytic vesicle
internalisation. Myo3-N production in vps13Δ results in restoration
of the lifetime of Myo3 patches engaged in invagination and in
release of endocytic vesicles, and in partially shortened lifetimes of
Las17 and Myo5. Myo3-N production may also have other effects
and it should also be noted that the vesicle internalisation defect of
vps13Δ is not corrected. It was recently documented that endocytic
plasma membrane invaginations associate with the cortical ER and
this contact facilitates actin polymerisation and endocytic vesicle
scission (Encinar del Dedo et al., 2017). Myo5 is a protein that
establishes the contact between the ER and endocytic sites by
binding Osh2 and Osh3. Osh2/3 in turn bind Scs2 and Scs22, ER
membrane proteins, and the Osh2 sterol transfer domain is required
for the onset of actin polymerisation at endocytic sites (Encinar del
Dedo et al., 2017).Myo3 exhibits a similar domain structure toMyo5
and can possibly perform similar functions at endocytic sites.
Previous results are consistent with the view that type I myosin could
induce formation of ER-plasma membrane contact sites and this
capacity is required for myosin-Osh2/3-Scs2/22 link and the sterol
transfer activity of Osh2, actin polymerisation and endocytic vesicle
scission (Encinar del Dedo et al., 2017). In the osh2Δ osh3Δ and
scs2Δ scs22Δ strains, the lifespan of Abp1 patches was increased,
with a high fraction of patches initiating the inward movement and
retracting back to the plasma membrane (Encinar del Dedo et al.,
2017), similar to what we observed for vps13Δ. Our results showing
that vps13Δ defects in endocytosis are suppressed byMYO3-N in an
Osh2/3-dependent way suggest that one mechanism of suppression
could be by promoting the formation of ER-plasma membrane
connections at endocytic sites, which involve type I myosin. Also, a
recent report suggests that Vps13 could be a binding partner of Osh2
(Bean et al., 2018). This implies a possible Vps13 function in the
formation of ER-plasma membrane contact sites, which are
important for maintaining the lipid and protein composition of
Fig. 8. The osh2Δ osh3Δ double mutant is hypersensitive to SDS and
Osh2/3 are important for vps13Δ suppression by MYO3-N.
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plasma membrane and are a prerequisite for SDS-stress survival. A
more efficient action of myosin in promoting sterol transfer by
Osh2/3 at endocytic sites helps to overcome the defects caused by the
lack of Vps13. This suggests that: Vps13 may be important for the
transfer of some lipids to plasma membranes at some ER-lasma
membrane contact sites; a lack of Vps13 participation in the
formation of contact sites affects endocytosis; and this defect could
be overcome by activation of endocytic ER-plasma membrane
contact sites. This model is supported by a recent study in which the
N-terminal fragment of Vps13 was shown to be able to transfer the
bulk of glycerolipids between liposomes (Kumar et al., 2018),
implying that Vps13 might relocate lipids between membranes.
Such transfer could possibly be required for growth of plasma
membrane invagination or vesicle scission during the internalisation
step of endocytosis. It requires further study to find out whether the
role of Vps13 in endocytosis is direct, since the SDS growth and
endocytosis defect of vps13Δ may result also from activation of
calcium signalling. Since the growth defect of vps13Δ on SDS
medium is more severe than that of pmc1Δ, the activation of calcium
signalling is probably not the only reason and othermechanismsmay
contribute.
In this study, we demonstrate the relationship between Vps13 and
calcium signalling, and the importance of Osh2/3-dependent
membrane contact sites for bypassing the vps13Δ growth defect.
Our results will be helpful for studies to better understand the
pathogenesis of ChAc in higher eukaryotes and in cell lines. The
multicopy suppressor that we selected can suppress the other
phenotypes of vps13Δ, not just the SDS hypersensitivity. In
addition, chemical compounds such as EGTA or FK506 can
suppress the SDS hypersensitivity. Thus, we believe that this
phenotype is useful to learn about pathways that could be potential
targets for chemical intervention, and could be used directly to
screen for drugs to treat ChAc.
MATERIALS AND METHODS
Strains, media and growth conditions
Escherichia coli strain DH5α was used for plasmid propagation. The yeast
S. cerevisiae strains used in this study are listed in Table S1. For genetic
analysis, strains BY4741 cnb1Δ vps13Δ and BY4741 crz1Δ vps13Δ were
constructed by deletion of VPS13 using the vps13::URA3 cassette
(pKA475) in the single-deletion strains BY4741 cnb1Δ and BY4741
crz1Δ. Gene disruptions were performed by transformation of yeast cells
with a PCR product containing theURA3 selection marker flanked by 50 bp
of homology to the 5′ and 3′ regions of VPS13. The vps13::URA3 cassette
was also used to construct strains encoding Las17-mRFP, Myo3-GFP,
Myo5-GFP or Abp1-mCherry endocytic markers in the genome and devoid
of Vps13 protein. Genomic integrations were confirmed by PCR on
genomic DNA.
Yeast were grown at 30°C in liquid YPD complete medium (1% yeast
extract, 2% peptone, 2% glucose) or in synthetic SC medium (0.067% yeast
nitrogen base without amino acids, 2% glucose) with desired supplements
(adenine, uracil, amino acids) (all media ingredients: DB, Sparks, USA). For
growth tests, cells were grown overnight in liquid media and cultures were
diluted with water to obtain a cell density equal to OD600∼1. Subsequently,
aliquots of 4-fold serial dilutions of cells were spotted on plates with solid
media. Media used for growth tests were YPD with, or without, addition of
SDS (Sigma-Aldrich, St Louis, USA), and SC-leu-arg with, or without,
addition of canavanine (Sigma-Aldrich), as described in the figure legends.
Plates were incubated at 30°C for 2 (YPD) or 3 (YPD+SDS) days, or as
indicated. Mutant cells were very sensitive to small changes in SDS
concentration and final SDS concentration in the medium strongly depends
on the lot of medium and lot of SDS stock solution, and various physical
factors; therefore, each growth experiment was performed using several
dilutions of SDS stock solution and a representative result is shown. For
two-hybrid analysis, the PJ69-4A strain was used and respective
transformants were grown on SC-trp-leu plates, replicated on SC-trp-leu-
his supplemented with 1.5 mM aminotriazol (Sigma-Aldrich) and incubated
for 3-5 days. Liquid cultures were inoculated with a mix of several yeast
colonies obtained after transformation. Growth tests were repeated at least
twice. Plates were scanned by HP Scanjet G4010 or Epson Perfection 2480
Photo scanner. Imagines were processed with Adobe Photoshop 6.0.
Plasmids
Plasmids used are described in Table S2. To subclone the MYO3 gene
fragment, the BamHI and SalI DNA fragment from the original clone from
the genomic bank was transferred into pRS425-PGPD vector to obtain
pRS425-PGPD-MYO3-N. Further transferring a 3.2 kb BamHI HindIII
fragment of pRS425-PGPD-MYO3-N to pRS425-PGPD generated pRS425-
PGPD-MYO3-NΔ680-775. To destroy calmodulin-binding motifs IQ1 and
IQ2 in Myo3-N, mutations were introduced in the MYO3-N fragment, after
subcloning into pUC19 using PstI and SalI enzymes, by one-step site-
directed mutagenesis. Three plasmids were obtained: pUC19-MYO3-iq1,
encoding myosin fragment with I725G and Q726G substitutions; pUC19-
MYO3-iq2, encoding protein with I743G and Q744G substitutions; and
pUC19-MYO3-iq1/2, encoding protein with all four substitutions. Next, the
PstI-SalI fragments were transferred back to create pRS425-PGPD-myo3-
iq1, pRS425-PGPD-myo3-iq2 and pRS425-PGPD-myo3-iq1/2. pRS425-
PGPD-MYO3-N-HA and pRS425-PGPD-myo3-iq1/2-HA were generated
by introducing the HA tag into the SalI polylinker restriction site. Sequences
of oligonucleotides used in this study are available upon request.
To construct plasmids for two-hybrid systems, the CMD1 gene and
mutated alleles were amplified by PCR using YEplac181lac bearing CMD1,
cmd1-226, cmd1-228, cmd1-231 or cmd1-239 alleles as the templates. PCR
products were digested with PstI and BamHI and were cloned into
pGAD424. To obtain pGBT9-MYO3-N or pGBT9-myo3-iq1/2, the
appropriate fragments were amplified by PCR with pRS425-PGPD-
MYO3-N or pRS425-PGPD-myo3-iq1/2 as the templates. PCR products
were cloned into EcoRI and SalI sites of pGBT9.
Screen for multicopy suppressors of vps13-I2749Rmutation
The vps13Δ [vps13-I2749R] cells were transformed with pFL44-based
genomic bank (Kabir et al., 2005), plated on SC-ura-leu plates and incubated
at 30°C for 3 days. Then, transformants were replicated on YPD plates with
addition of 0.03% SDS and incubated at 30°C for 3 days. Positive clones
were isolated and grown in SC-ura liquid medium for plasmid isolation.
Plasmids were retransformed and suppression of the vps13Δ [vps13-I2749R]
growth defect was confirmed.
Actin staining and fluorescence microscopy
For actin staining, cells were grown in SC-leu medium to log-phase, fixed
with formaldehyde (Sigma-Aldrich for 2 h, washed and stained with Alexa-
Fluor-546-conjugated phalloidin (Thermo Fisher Scientific, Waltham,
USA). Cells were viewed with an Eclipse E800 (Nikon, Tokyo, Japan)
fluorescence microscope equipped with a DS-5Mc camera (Nikon, Tokyo,
Japan). Images were collected using Lucia General 5.1 software (Laboratory
Imaging Ltd, Prague, Czech Republic). The same fields were viewed by
differential interference contrast (DIC) optics. All samples in the experiment
were encoded and the microscope observations and quantifications were
performed blindly. Charts and statistical analyses were done usingMicrosoft
Excel.
For live-cell imaging, cells expressing tagged proteins were visualised
after growing to early log-phase in synthetic medium with appropriate
supplements. Epifluorescence microscopy was performed using Olympus
IX-81 inverted microscope (Olympus, Tokyo, Japan) with a DeltaVision RT
Restoration Microscopy System (using a 100×/1.40 NA oil objective) and
Photometrics Coolsnap HQ camera, with imaging and image capture
performed using SoftWoRx™ image analysis and model-building
application (Applied Precision Instruments, Seattle, USA). Live-cell
imaging of GFP-tagged Las17 and mCherry-tagged Abp1 proteins was
performed with 1 s time lapse. All image data sets were deconvolved, using
the SoftWoRx application. Live-cell images of Myo3-GFP and Myo5-GFP
were acquired using OMXDeltaVision V4 microscope (GE Healthcare Life
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Sciences, Chicago, USA) and a 60× USPLAPO (1.42 NA) objective with
refractive index 0.1514 immersion oil (Cargille, Cedar Grove, USA) with
0.5 s time lapse. Samples were illuminated using Insight Solid State
Illuminator (10%), and images were taken simultaneously on separate
scientific complementary metal oxide semiconductor (sCMOS) cameras
(30 ms exposure). Seven 250 nm sections were acquired every 500 ms (181
time points). The stacks were then deconvolved and processed, using
SoftWorx, to produce a movie composed of maximum intensity projections
at each time point. The Myo3-/Myo5-GFP lifetime was analysed from those
projections. Movies and kymographs were assembled using Fiji software.
Charts and statistical analyses were done in GraphPad Prism (https://www.
graphpad.com/scientific-software/prism/, 02.08.2018).
Western blot analysis
Yeast cells were grown at 30°C in SC-ura-leu to the log-phase. Protein
extracts were prepared after disrupting cells with glass beads as described
(Rzepnikowska et al., 2017a) or alkaline lysis (Yaffe and Schatz, 1984).
Samples were analysed by standard SDS-PAGE followed by western
blotting using mouse monoclonal anti-Pgk1 (dilution 1:20,000, Molecular
Probes Cat# A-6457, RRID:AB_221541, Thermo Fisher Scientific),
monoclonal anti-HA epitope (dilution 1:2000, Cat# 901503, BioLegend,
San Diego, USA), rabbit anti-phospho-p44/42 MAPK (Erk1/2) (Thr202/
Thr204; dilution 1:1000, Antibody #9101, Cell Signalling Technology,
Danvers, USA; validation: Pérez et al., 2016), recognising phospho-Slt2,
antibodies. Secondary anti-mouse or anti-rabbit IgG horseradish peroxidase
(HRP)-conjugated antibodies (dilution 1:2000, Dako, Glostrup, Denmark)
were also used. Signal was detected by enhanced chemiluminescence
(Millipore, Darmstadt, Germany). Densitometry was performed with
ImageJ (https://imagej.nih.gov/ij/, 02.08.2018). Chart and statistical
analyses were done in GraphPad Prism.
β-galactosidase activity
For the β-galactosidase activity assay, cells were grown overnight in SC-ura
or SC-ura-leu, collected and extracts prepared with glass beads. Activity of
β-galactosidase was analysed as described (Kamin ́ska et al., 2005). In each
of three experiments, at least three independent transformants of respective
yeast strains were inoculated, and their extracts were assayed in duplicates.
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